Maze Therapeutics, Inc. ($MAZE)
Filing Information
| Accession Number | 0002050422-26-000003 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 6, 2026 |
| Document Date | Jan 2, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
15,000
Total Value
$247,853.59
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, Finance | Common Stock | โ | Jan 2, 2026 | Exercise/Conversion | 204 | $10.42 | $2,125.68 | 13,169 | Direct | โ | View Details | |
SVP, Finance | Common Stock | โ | Jan 2, 2026 | Exercise/Conversion | 4,796 | $10.42 | $49,974.32 | 17,965 | Direct | โ | View Details | |
SVP, Finance | Common Stock | โ | Jan 2, 2026 | Sale | 2,405 | $38.70 | $93,072.30 | 15,560 | Direct | โ | View Details | |
SVP, Finance | Common Stock | โ | Jan 2, 2026 | Sale | 2,595 | $39.57 | $102,681.30 | 12,965 | Direct | โ | View Details | |
SVP, Finance | Stock Option (Right to Buy) | Derivative | Jan 2, 2026 | Exercise/Conversion | 204 | $0.00 | $0.00 | 2,377 | Direct | โ | View Details | |
SVP, Finance | Stock Option (Right to Buy) | Derivative | Jan 2, 2026 | Exercise/Conversion | 4,796 | $0.00 | $0.00 | 2,983 | Direct | โ | View Details |